跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
DBL MORPHINE SULFATE 5mg/1mL injection ampoule
Approved
STANDARD
DBL MORPHINE SULFATE 5mg/1mL injection ampoule
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
22b4ff27b7102392
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
22b4ff27b7102392
Product Name
DBL MORPHINE SULFATE 5mg/1mL injection ampoule
Artg Id
121754
Artg Name
DBL MORPHINE SULFATE 5mg/1mL injection ampoule
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
2005-12-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d6d661fe1cf1060723c7530d26c0defc.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/5252af86f1fffeb57ea0d087f6dcd5d2.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
22b4ff27b7102392
Type
Standard
Back to TGA Approvals
DBL MORPHINE SULFATE 5mg/1mL injection ampoule - TGA Drug Approval Details
